Knowit AB (0GNK)
London Stock Exchange · UK · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 116.00 |
|---|---|
| 52-week range | 77.10 – 131.50 |
| Return, 1 month / 3 months | +21.5% / +29.2% |
| Return, 1 year / 3 years | −3.4% / −9.9% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 41.9% |
| Worst drawdown (1 year) | -40.4% |
| Average daily value traded | 0.13M SEK |
| Dividend yield | 2.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Knowit AB is a consultancy based in Sweden that helps organisations with digital development. Its consultants work on software engineering, design and user experience, and the management of digital systems and information. Customers include businesses and public sector bodies, mainly in the Nordic countries, who rely on the firm for advice and project work in areas such as digital channels, data and cloud-based systems. The company also offers services in management consulting and cyber security.
Knowit AB trades under the code 0GNK on the London Stock Exchange in UK, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Knowit AB (0GNK) trades on the London Stock Exchange in UK. It last closed at SEK 116.00 on 27 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 2,182 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 3.4% and over the last three months it rose 29.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 18.8% | ||
| From 52-week high | -11.8% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 29.2% | ||
| 6-month return | 20.1% | ||
| 12-month return, skipping the last month | -20.5% | ||
| Stability (higher is calmer) | 34 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 41.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.4% | ||
| Liquidity | 23 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.13M SEK | ||
| Zero-volume days | 35.0% | ||
| Income | 39 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.1% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +14.2% |
|---|---|
| 1 month | +21.5% |
| 3 months | +29.2% |
| 6 months | +20.1% |
| 1 year | −3.4% |
| 3 years | −9.9% |
| 5 years | −62.5% |
Signals
| 50-day / 200-day average | 96.71 / 97.68 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 9.15 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Apr 2026 | SEK 1.2500 |
| 17 Nov 2025 | SEK 1.1500 |
| 30 Apr 2025 | SEK 1.1500 |
| 15 Nov 2024 | SEK 2.6000 |
| 3 May 2024 | SEK 2.6000 |
| 15 Nov 2023 | SEK 3.7500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.